These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31863499)

  • 1. Exploratory identification of predictive biomarkers in randomized trials with normal endpoints.
    Krzykalla J; Benner A; Kopp-Schneider A
    Stat Med; 2020 Mar; 39(7):923-939. PubMed ID: 31863499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations.
    Huber C; Benda N; Friede T
    Pharm Stat; 2019 Oct; 18(5):600-626. PubMed ID: 31270933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual treatment effect prediction for amyotrophic lateral sclerosis patients.
    Seibold H; Zeileis A; Hothorn T
    Stat Methods Med Res; 2018 Oct; 27(10):3104-3125. PubMed ID: 29298618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-Based Recursive Partitioning for Subgroup Analyses.
    Seibold H; Zeileis A; Hothorn T
    Int J Biostat; 2016 May; 12(1):45-63. PubMed ID: 27227717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subgroup identification in dose-finding trials via model-based recursive partitioning.
    Thomas M; Bornkamp B; Seibold H
    Stat Med; 2018 May; 37(10):1608-1624. PubMed ID: 29388228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian additive decision trees of biomarker by treatment interactions for predictive biomarker detection and subgroup identification.
    Zhao Y; Zheng W; Zhuo DY; Lu Y; Ma X; Liu H; Zeng Z; Laird G
    J Biopharm Stat; 2018; 28(3):534-549. PubMed ID: 29020511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a model-based recursive partitioning algorithm to predict crash frequency.
    Tang H; Donnell ET
    Accid Anal Prev; 2019 Nov; 132():105274. PubMed ID: 31446099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using recursive partitioning to account for parameter heterogeneity in multinomial processing tree models.
    Wickelmaier F; Zeileis A
    Behav Res Methods; 2018 Jun; 50(3):1217-1233. PubMed ID: 28779459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk controlled decision trees and random forests for precision Medicine.
    Doubleday K; Zhou J; Zhou H; Fu H
    Stat Med; 2022 Feb; 41(4):719-735. PubMed ID: 34786731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Dynamic Bayesian Network model for the simulation of Amyotrophic Lateral Sclerosis progression.
    Zandonà A; Vasta R; Chiò A; Di Camillo B
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):118. PubMed ID: 30999865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian population finding with biomarkers in a randomized clinical trial.
    Morita S; Müller P
    Biometrics; 2017 Dec; 73(4):1355-1365. PubMed ID: 28257141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subgroup identification using covariate-adjusted interaction trees.
    Steingrimsson JA; Yang J
    Stat Med; 2019 Sep; 38(21):3974-3984. PubMed ID: 31162690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized Risk Prediction in Clinical Oncology Research: Applications and Practical Issues Using Survival Trees and Random Forests.
    Hu C; Steingrimsson JA
    J Biopharm Stat; 2018; 28(2):333-349. PubMed ID: 29048993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.
    Radunovic A; Annane D; Rafiq MK; Mustfa N
    Cochrane Database Syst Rev; 2013 Mar; (3):CD004427. PubMed ID: 23543531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simulation study on estimating biomarker-treatment interaction effects in randomized trials with prognostic variables.
    Haller B; Ulm K
    Trials; 2018 Feb; 19(1):128. PubMed ID: 29463271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing interaction between treatment and high-dimensional covariates in randomized clinical trials.
    Callegaro A; Spiessens B; Dizier B; Montoya FU; van Houwelingen HC
    Biom J; 2017 Jul; 59(4):672-684. PubMed ID: 27763683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Recursive Partitioning Analysis in Clinical Trials and Meta-Analysis of Randomized Clinical Trials, 1990-2016.
    Fors MM; Viada CE; Gonzalez P
    Rev Recent Clin Trials; 2017; 12(1):3-7. PubMed ID: 27633964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.